(Q45288675)

11 December 2017

title

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells (English)

1 reference

11 December 2017

main subject

plasmablastic lymphoma

1 reference

5

David L Porter

1 reference

11 December 2017

7

Jane L Liesveld

1 reference

11 December 2017

Andrew G Evans

1

1 reference

11 December 2017

Paul G Rothberg

2

1 reference

11 December 2017

W Richard Burack

3

1 reference

11 December 2017

Scott F Huntington

4

1 reference

11 December 2017

Jonathan W Friedberg

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

18 June 2015

1 reference

British Journal of Haematology

11 December 2017

published in

1 reference

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

11 December 2017

cites work

1 reference

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

21 January 2018

1 reference

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

21 January 2018

1 reference

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

21 January 2018

1 reference

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

21 January 2018

1 reference

Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.

21 January 2018

1 reference

Chimeric antigen receptor T cells for sustained remissions in leukemia

21 January 2018

1 reference

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

21 January 2018

1 reference

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

An antibody-deficiency syndrome due to mutations in the CD19 gene

21 January 2018

1 reference

CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13562

0 references

1 reference